ABC00781JP

Itraconazole hydroxy n-butyltriazolone impurity

Itraconazole hydroxy n-butyltriazolone impurity is a synthetic byproduct arising from the triazolone ring formation pathway in itraconazole synthesis, featuring a hydroxylated n-butyl substituent at the triazole core. Its structure incorporates a 1H-1,2,4-triazol-1-yl moiety linked to a hydroxybutyl chain, with a fused benzyl and isopropyl group maintaining stereochemical similarity to the parent API. This impurity results from competitive hydroxylation and alkylation during triazole cyclization, leading to a stable, thermodynamically favored side product. It serves as a critical HPLC reference standard for quantifying process-related impurities in itraconazole drug substance.

On Request
Molecular Formula C22H27N5O2
Molecular Weight 393.5000
CAS Number 89848-20-4 โœ“ Verified
PubChem CID 15125563 โ†—
Purity N/A
Product Type API Impurity
Parent Drug Itraconazole
Lead Time On Request
IUPAC Name 2-butyl-4-[4-[4-(4-hydroxyphenyl)piperazin-1-yl]phenyl]-1,2,4-triazol-3-one

๐Ÿ“ Synonyms

89848-20-4 Itraconazole Hydroxy Butyltriazolone Impurity SCHEMBL9279160 QOMBPWRCFXEVRW-UHFFFAOYSA-N 1-Butyl-4-(4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)-1H-1,2,4-triazol-5(4H)-one 4-[4-[4-[4-Hydroxyphenyl]piperazin-1-yl]phenyl]-2-butyl-2,4-dihydro-3H-1,2,4-triazol-3-one

๐Ÿ”ฌ Chemical Identifiers

CCCCN1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)O
InChI=1S/C22H27N5O2/c1-2-3-12-27-22(29)26(17-23-27)20-6-4-18(5-7-20)24-13-15-25(16-14-24)19-8-10-21(28)11-9-19/h4-11,17,28H,2-3,12-16H2,1H3
QOMBPWRCFXEVRW-UHFFFAOYSA-N

Related Products